Latest News
Brain Metastasis in ALK+ Disease
In ALK+ NSCLC the brain is often involved at diagnosis, not late. Why CNS efficacy must be a primary treatment selection criterion, and what to monitor.
Cognitive and Mood Changes on Lorlatinib
CNS effects on lorlatinib are usually early, Grade 1–2, and reversible. The real risk is delayed recognition. How to interrupt rapidly and re-initiate safely.
Peripheral Neuropathy on Lorlatinib
Neuropathy on lorlatinib often begins subtly and can persist if ignored. How to recognise the pattern, assess functional impact, and keep patients on therapy safely.
Peripheral Edema on Lorlatinib
Peripheral edema is common on lorlatinib. How to distinguish benign swelling from functionally limiting cases, and manage it stepwise without interrupting therapy.
Managing Weight Gain on Lorlatinib in ALK+ NSCLC
Weight gain occurred in approximately 44% of patients on lorlatinib in long-term CROWN follow-up. How to recognise the pattern early and counsel patients realistically.
The PMMR Framework for Lorlatinib Adverse Events
Prepare, Monitor, Manage, Reassess: a practical framework for keeping patients with ALK-positive NSCLC on lorlatinib. Presented by Dr. Geoffrey Liu.
Biologics for COPD: A Practical Guide for Clinicians
Dr. Stephanie Christenson discusses COPD biologics, eosinophil biomarkers and trial evidence in Season 8 of The eXpand Podcast.
COPD Enters the Biologic Era: Are Your Patients Ready?
Explore how biologic therapies are transforming COPD care. Dr. MeiLan Han breaks down biomarkers, clinical trials, and patient selection in Season 8 of the eXpand Podcast.
Preventing Respiratory Infections in Indigenous Communities
Practical strategies to prevent respiratory infections in Indigenous and remote communities, including early intervention and community engagement.
Early Treatment for COVID-19 in Remote Communities
Learn why early testing and antiviral treatment are critical for respiratory infections in remote and Indigenous communities.
Webinar Replay
Optimal Practice and Vaccination Update for Your Respiratory Patients
On-demand
